Kancelaria Medius (WAR:KME) 1-Year Sharpe Ratio: -0.71 (As of Aug. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:KME Kancelaria Medius SA WAR:KME
29 GF Score
Price zł0.23
GF Value zł0.19
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Kancelaria Medius 1-Year Sharpe Ratio?

Kancelaria Medius WAR:KME 29 1-Year Sharpe Ratio is -0.71 as of Aug. 26, 2026. GuruFocus rates WAR:KME with a GF Score™ of 29/100 and a GF Value™ of zł0.19 (Modestly Overvalued). The stock has 4 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-08-26), Kancelaria Medius's 1-Year Sharpe Ratio is -0.71.

Kancelaria Medius  (WAR:KME) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Kancelaria Medius 1-Year Sharpe Ratio Related Terms

WAR:KME vs CTAS, CPRT, GPN: 1-Year Sharpe Ratio Comparison

For the Specialty Business Services subindustry, Kancelaria Medius's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kancelaria Medius 1-Year Sharpe Ratio vs Business Services Industry

For the Business Services industry and Industrials sector, Kancelaria Medius's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Kancelaria Medius's 1-Year Sharpe Ratio falls into.


WAR:KME
29GF Score
Kancelaria Medius SA WAR:KME
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kancelaria Medius 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of -0.71 mean?
Kancelaria Medius (WAR:KME) has a 1-Year Sharpe Ratio of -0.71 as of Aug. 26, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Kancelaria Medius and its competitors.
Is Kancelaria Medius' 1-Year Sharpe Ratio too high?
Kancelaria Medius' current 1-Year Sharpe Ratio is -0.71. Overall, Kancelaria Medius has a GF Score™ of 29/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kancelaria Medius' 1-Year Sharpe Ratio compare to CTAS and CPRT?
Kancelaria Medius' 1-Year Sharpe Ratio of -0.71 can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Business Services company?
A good 1-Year Sharpe Ratio depends on the Business Services industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Kancelaria Medius and its competitors. Kancelaria Medius's current 1-Year Sharpe Ratio is -0.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kancelaria Medius stock overvalued right now?
Based on GuruFocus' analysis, Kancelaria Medius (WAR:KME) is currently considered Modestly Overvalued. The stock's GF Value™ is zł0.19, compared to a current price of zł0.23 — trading 21.1% above its estimated fair value. The current 1-Year Sharpe Ratio is -0.71. Kancelaria Medius' overall GF Score™ is 29/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Kancelaria Medius (WAR:KME), the current 1-Year Sharpe Ratio is -0.71 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kancelaria Medius (WAR:KME) Overvalued in 2026?

Based on GuruFocus' analysis, Kancelaria Medius stock appears to be overvalued. The current stock price of zł0.23 is trading 21.1% above its estimated GF Value™ of zł0.19. GuruFocus considers Kancelaria Medius to be Modestly Overvalued.

Key valuation signals for WAR:KME:

  • 1-Year Sharpe Ratio: -0.71
  • GF Value™: zł0.19 vs. price of zł0.23 (21.1% above fair value)
  • GF Score™: 29/100 with 4 warning signs

No single metric tells the full story. See the WAR:KME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kancelaria Medius Business Description

Address ul. Babinski 69, Krakow, POL, 30-126
Kancelaria Medius SA is a Poland based company involved in providing debt management and receivables management services. The various services offered by the company include Purchase of debt portfolios, Debt service, Handling of mortgage-secured claims and Law Firm services.
29GF Score

Get the complete analysis for WAR:KME

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.23
Price
zł0.19
GF Value